Abstract
7082 Background: AMR is a synthetic anthracycline with activity in small cell lung cancer (SCLC). Cyclophosphamide is an alkylating agent commonly combined with anthracyclines in diseases such as b...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
